Eugene Braunwald

Brigham and Women's Hospital — United States

Medicine · Health Sciences

127h-index92.0kcitations592works9.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myocardial Infarction Research(229), Cardiac Imaging and Diagnostics(149), Coronary Interventions and Diagnostics(96), Heart Failure Treatment and Management(89), Cardiovascular Function and Risk Factors(89)

Publications588 total

Bayesian Machine Learning Model Guiding Iterative, Personalized Anticoagulant Dosing Decision-Making
JACC Advances·2025Open Access
Classification and Diagnosis of Acute Coronary Syndromes
Elsevier eBooks·2025
Contributors
Elsevier eBooks·2025
Abstract 4364163: Polygenic Risk Score for Abdominal Aortic Aneurysm in Patients with Cardiometabolic Disease: Analysis of 40,000 Patients from 3 TIMI Trials
Circulation·2025
Fibrinolytic Therapy for Thromboembolic Diseases
Journal of the American College of Cardiology·2025
A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular Risk
Journal of the American College of Cardiology·2025· 1 cited
Vulnerable or High-Risk Plaque
JACC. Cardiovascular imaging·2025· 40 citedOpen Access
Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis—The Time Has Come
JAMA Cardiology·2025· 14 cited
Win Ratio Sensitivity Analysis Using A Modified Hierarchical Composite Outcome: Insights From The Paraglide-hf
Journal of Cardiac Failure·2025
Mortality After High-Risk Myocardial Infarction Over the Last 20 Years: Insights from the VALIANT and PARADISE-MI Trials
European Journal of Heart Failure·2024· 4 citedOpen Access
Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials
Nature Medicine·2024· 32 citedOpen Access
Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation
JAMA Cardiology·2024· 21 citedOpen Access
CONCURRENT EVALUATION OF HSTNI AND HSTNT AND THEIR ASSOCIATIONS WITH CARDIOVASCULAR EVENTS IN 37,886 PATIENTS WITH STABLE ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
Journal of the American College of Cardiology·2024
Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications
Seminars in Thrombosis and Hemostasis·2024· 14 cited
Novel Polygenic Risk Score and Established Clinical Risk Factors for Risk Estimation of Aortic Stenosis
JAMA Cardiology·2024· 17 citedOpen Access
Natriuretic Peptides, Body Mass Index and Heart Failure Risk: Pooled Analyses of SAVOR-TIMI 53, DECLARE-TIMI 58 and CAMELLIA-TIMI 61
European Journal of Heart Failure·2023· 9 citedOpen Access
Sacubitril/Valsartan Compared to Ramipril in High-Risk Post-Myocardial Infarction Patients Stratified According to Use of Mineralocorticoid Receptor Antagonists: Insight from the PARADISE MI Trial
European Journal of Heart Failure·2023· 4 citedOpen Access
Reduction in the risk of major adverse limb events with ezetimibe versus placebo in addition to statin therapy: insights from the IMPROVE IT trial
European Heart Journal·2023· 4 citedOpen Access
Risk and benefits of baseline antiplatelet therapy in 58,598 patients with atrial fibrillation randomized to NOACs vs warfarin
European Heart Journal·2023· 1 citedOpen Access
The First Patient Clinically Diagnosed with Hypertrophic Cardiomyopathy
Case Reports in Cardiology·2023Open Access
page 1 of 30Next →

Frequent Co-authors

Carolyn H. McCabe(13), Christopher P. Cannon(12), Marc A. Pfeffer(11), Elliott M. Antman(9), C. Michael Gibson(9), Sabina A. Murphy(8), David A. Morrow(7), Lemuel A. Moyé(5), Pierre Théroux(5), Robert A. Kloner(5), James A. de Lemos(5), Gervasio A. Lamas(4), Jean L. Rouleau(4), Valentı́n Fuster(4), Robert P. Giugliano(4), Frans Van de Werf(4), Jacques R. Rouleau(3), John D. Rutherford(3), John W. Beasley(3), Robert M. Califf(3)